Issue Navigation
-
Review
-
118-123
Li Q, Wang J, Tang Y, Lu HZ
Drug Discov Ther. 2021; 15(3):118-123.
DOI: 10.5582/ddt.2021.01058
-
124-129
Antimicrobial resistance and COVID-19 syndemic: Impact on public health
Vidyarthi AJ, Das A, Chaudhry R
Drug Discov Ther. 2021; 15(3):124-129.
DOI: 10.5582/ddt.2021.01052
-
130-138
Management of dengue with co-infections: an updated narrative review
Begam NN, Kumar A, Sahu M, Soneja M, Bhatt M, Vishwakarma VK, Sethi P, Baitha U, Barua K, Biswas A
Drug Discov Ther. 2021; 15(3):130-138.
DOI: 10.5582/ddt.2021.01027
-
139-142
Applying the silkworm model for the search of immunosuppressants
Miyashita A, Hamamoto H, Sekimizu K
Drug Discov Ther. 2021; 15(3):139-142.
DOI: 10.5582/ddt.2021.01041
-
143-149
Tohda M, Zhao Q, Kobayashi N, Kazuma K
Drug Discov Ther. 2021; 15(3):143-149.
DOI: 10.5582/ddt.2021.01037
-
150-155
Tanaka H, Ohyama K, Horikomi Y, Ishii T
Drug Discov Ther. 2021; 15(3):150-155.
DOI: 10.5582/ddt.2021.01053
-
156-161
Chopra N, Chowdhury M, Singh AK, Khan MA, Kumar A, Ranjan P, Desai D, Wig N
Drug Discov Ther. 2021; 15(3):156-161.
DOI: 10.5582/ddt.2021.01014
-
162-165
The clinical significance of cytokeratin 20 staining pattern in Merkel cell carcinoma
Sakata Y, Inaba Y, Kunimoto K, Kaminaka C, Yamamoto Y, Iwahashi Y, Murata S, Asamura S, Jinnin M
Drug Discov Ther. 2021; 15(3):162-165.
DOI: 10.5582/ddt.2021.01043
-
166-168
Aducanumab: The first targeted Alzheimer's therapy
Yang P, Sun FS
Drug Discov Ther. 2021; 15(3):166-168.
DOI: 10.5582/ddt.2021.01061
-
169-170
Kosaka H, Kaibori M, Kariya S, Ueno Y, Matsui K, Yamamoto H, Matsushima H, Hamamoto T, Sekimoto M
Drug Discov Ther. 2021; 15(3):169-170.
DOI: 10.5582/ddt.2021.01055